Gabapentin
Product Images NDC 68788-7847

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-7847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Tablets 600mg Tablets

Gabapentin Tablets 600mg Tablets
Gabapentin Tablets 600mg are used for patients as prescribed by their doctor. These tablets are generic for Neurontin and each film-coated tablet contains 600mg of Gabapentin. It is important to note that federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Instructions are also available in Spanish. Lot and batch numbers are provided on the packaging.*
FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
This is a chart showing the mean pain scores for two different treatment groups (fixed dose and dose titration) compared to a placebo group. The chart also includes information on the medication Gabapentin at a dosage of 3600 mg/day. The pain scores are measured at baseline and over a period of multiple weeks.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This is a graph showing the mean pain score for different treatments (placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day) over a 4-week fixed dose period. The x-axis represents the weeks and the y-axis represents the pain score.*
FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Image-04 (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.